Postmarketing studies of drug safety

被引：8
|
作者：
Schneeweiss, Sebastian
Avorn, Jerry
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷
关键词：
CLINICAL-TRIALS;
D O I：
10.1136/bmj.d342
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Postmarketing Studies: The Work of the Drug Safety Research Unit
    David J. Finney
    Drug Safety, 1999, 21 : 337 - 338
  • [2] Postmarketing studies: The work of the Drug Safety Research Unit
    Finney, DJ
    DRUG SAFETY, 1999, 21 (04) : 337 - 338
  • [3] Drug Postmarketing Studies
    Kashoki, Mwango
    Lee, Cathryn
    Jenkins, John
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (22): : 2459 - 2459
  • [4] Postmarketing surveillance for drug safety
    Holden, WL
    Scarazzini, LJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 503 - 503
  • [5] Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies
    Sinaci, A. Anil
    Erturkmen, Gokce B. Laleci
    Gonul, Suat
    Yuksel, Mustafa
    Invernizzi, Paolo
    Thakrar, Bharat
    Pacaci, Anil
    Cinar, H. Alper
    Cicekli, Nihan Kesim
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [6] Postmarketing surveillance for drug safety - Reply
    Griffin, MR
    Stein, CM
    Ray, WA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (05) : 504 - 505
  • [7] POSTMARKETING STUDIES OF DRUG EFFICACY
    STROM, BL
    MELMON, KL
    MIETTINEN, OS
    ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) : 1791 - 1794
  • [8] POSTMARKETING DRUG SURVEILLANCE STUDIES
    FAICH, GA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (05) : 597 - 597
  • [9] A proposal for financing postmarketing drug safety studies by augmenting FDA user fees
    Carpenter, D
    HEALTH AFFAIRS, 2005, 24 (06) : W5469 - W5480
  • [10] An underrecognized challenge in evaluating postmarketing drug safety
    Roden, DM
    CIRCULATION, 2005, 111 (03) : 246 - 248
12345